Excitation, inhibition, local oscillations, or large-scale loops: What causes the symptoms of schizophrenia?

Current Opinion in Neurobiology

Volumn 22, Issue 3, 2012, Pages 537-544

  Lisman, John ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; DOPAMINE; GLUTAMATE DECARBOXYLASE 67; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROGRANIN;

BRAIN DYSFUNCTION; COGNITIVE DEFECT; DELTA RHYTHM; ELECTROENCEPHALOGRAPHY; GAMMA RHYTHM; GENE DELETION; HIPPOCAMPUS; HUMAN; NEGATIVE SYNDROME; NERVE CELL EXCITABILITY; NERVE CELL INHIBITION; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; OSCILLATION; POSITIVE SYNDROME; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; REVIEW; SCHIZOPHRENIA; THALAMUS MIDLINE NUCLEUS; THETA RHYTHM;

ANIMALS; BRAIN WAVES; ELECTROENCEPHALOGRAPHY; HUMANS; INHIBITION (PSYCHOLOGY); NEURAL PATHWAYS; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 84863484957     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2011.10.018     Document Type: Review

References (74)

1. Volk D.W., Lewis D.A. Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol Behav 2002, 77:501-505.
2. Spencer K.M. Visual gamma oscillations in schizophrenia: implications for understanding neural circuitry abnormalities. Clin EEG Neurosci Off J EEG Clin Neurosci Soc 2008, 39:65-68.
3. Galderisi S., Mucci A., Volpe U., Boutros N. Evidence-based medicine and electrophysiology in schizophrenia. Clin EEG Neurosci Off J EEG Clin Neurosci Soc 2009, 40:62-77.
4. Carlsson M.L., Carlsson A., Nilsson M. Schizophrenia: from dopamine to glutamate and back. Curr Med Chem 2004, 11:267-277.
5. Coyle J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006, 26:365-384.
6. Pilowsky L.S., Bressan R.A., Stone J.M., Erlandsson K., Mulligan R.S., Krystal J.H., Ell P.J. First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients. Mol Psychiatry 2006, 11:118-119.
7. Knable M.B., Weinberger D.R. Dopamine, the prefrontal cortex and schizophrenia. J Psychopharmacol 1997, 11:123-131.
8. Zhang Y., Behrens M.M., Lisman J.E. Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex. J Neurophysiol 2008, 100:959-965.
9. Kinney J.W., Davis C.N., Tabarean I., Conti B., Bartfai T., Behrens M.M. A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci Off J Soc Neurosci 2006, 26:1604-1615.
10. Lisman J.E., Coyle J.T., Green R.W., Javitt D.C., Benes F.M., Heckers S., Grace A.A. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 2008, 31:234-242.
11. Hayashi-Takagi A., Takaki M., Graziane N., Seshadri S., Murdoch H., Dunlop A.J., Makino Y., Seshadri A.J., Ishizuka K., Srivastava D.P., et al. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat Neurosci 2010, 13:327-332.
12. Hill J.J., Hashimoto T., Lewis D.A. Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 2006, 11:557-566.
13. Grunze H.C., Rainnie D.G., Hasselmo M.E., Barkai E., Hearn E.F., McCarley R.W., Greene R.W. NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci Off J Soc Neurosci 1996, 16:2034-2043.
14. Homayoun H., Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci Off J Soc Neurosci 2007, 27:11496-11500.
15. Lecourtier L., Homayoun H., Tamagnan G., Moghaddam B. Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-methyl-d-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex. Biol Psychiatry 2007, 62:739-746.
16. Homayoun H., Jackson M.E., Moghaddam B. Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats. J Neurophysiol 2005, 93:1989-2001.
17. Yizhar O., Fenno L.E., Prigge M., Schneider F., Davidson T.J., O'Shea D.J., Sohal V.S., Goshen I., Finkelstein J., Paz J.T., et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011, 477:171-178.
18. Durstewitz D., Seamans J.K. The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-o-methyltransferase genotypes and schizophrenia. Biol Psychiatry 2008, 64:739-749.
19. Mann E.O., Radcliffe C.A., Paulsen O. Hippocampal gamma-frequency oscillations: from interneurones to pyramidal cells, and back. J Physiol 2005, 562:55-63.
20. Bartos M., Vida I., Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci 2007, 8:45-56.
21. Borgers C., Kopell N. Effects of noisy drive on rhythms in networks of excitatory and inhibitory neurons. Neural Comput 2005, 17:557-608.
22. de Almeida L., Idiart M., Lisman J.E. A second function of gamma frequency oscillations: an E%-max winner-take-all mechanism selects which cells fire. J Neurosci Off J Soc Neurosci 2009, 29:7497-7503.
23. Singer W. Distributed processing and temporal codes in neuronal networks. Cogn Neurodyn 2009, 3:189-196.
24. Lisman J., Buzsaki G. A neural coding scheme formed by the combined function of gamma and theta oscillations. Schizophr Bull 2008, 34:974-980.
25. Uhlhaas P.J., Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 2010, 11:100-113.
26. Vierling-Claassen D., Siekmeier P., Stufflebeam S., Kopell N. Modeling GABA alterations in schizophrenia: a link between impaired inhibition and altered gamma and beta range auditory entrainment. J Neurophysiol 2008, 99:2656-2671.
27. Fuchs E.C., Zivkovic A.R., Cunningham M.O., Middleton S., Lebeau F.E., Bannerman D.M., Rozov A., Whittington M.A., Traub R.D., Rawlins J.N., et al. Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron 2007, 53:591-604.
28. Roopun A.K., Cunningham M.O., Racca C., Alter K., Traub R.D., Whittington M.A. Region-specific changes in gamma and beta2 rhythms in NMDA receptor dysfunction models of schizophrenia. Schizophr Bull 2008, 34:962-973.
29. Pinault D. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex. Biol Psychiatry 2008, 63:730-735.
30. Belforte J.E., Zsiros V., Sklar E.R., Jiang Z., Yu G., Li Y., Quinlan E.M., Nakazawa K. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 2010, 13:76-83.
31. Carlen M., Meletis K., Siegle J.H., Cardin J.A., Futai K., Vierling-Claassen D., Ruhlmann C., Jones S.R., Deisseroth K., Sheng M., et al. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol Psychiatry 2011.
32. Korotkova T., Fuchs E.C., Ponomarenko A., von Engelhardt J., Monyer H. NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 2010, 68:557-569.
33. Ferrarelli F., Massimini M., Peterson M.J., Riedner B.A., Lazar M., Murphy M.J., Huber R., Rosanova M., Alexander A.L., Kalin N., et al. Reduced evoked gamma oscillations in the frontal cortex in schizophrenia patients: a TMS/EEG study. Am J Psychiatry 2008, 165:996-1005.
34. Traub R.D., Whittington M.A., Buhl E.H., Jefferys J.G., Faulkner H.J. On the mechanism of the gamma→beta frequency shift in neuronal oscillations induced in rat hippocampal slices by tetanic stimulation. J Neurosci Off J Soc Neurosci 1999, 19:1088-1105.
35. Hashimoto T., Bazmi H.H., Mirnics K., Wu Q., Sampson A.R., Lewis D.A. Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry 2008, 165:479-489.
36. Martinez A., Hillyard S.A., Dias E.C., Hagler D.J., Butler P.D., Guilfoyle D.N., Jalbrzikowski M., Silipo G., Javitt D.C. Magnocellular pathway impairment in schizophrenia: evidence from functional magnetic resonance imaging. J Neurosci Off J Soc Neurosci 2008, 28:7492-7500.
37. Tamminga C.A., Stan A.D., Wagner A.D. The hippocampal formation in schizophrenia. Am J Psychiatry 2010, 167:1178-1193.
38. Ongur D., Cullen T.J., Wolf D.H., Rohan M., Barreira P., Zalesak M., Heckers S. The neural basis of relational memory deficits in schizophrenia. Arch Gen Psychiatry 2006, 63:356-365.
39. Luo A.H., Tahsili-Fahadan P., Wise R.A., Lupica C.R., Aston-Jones G. Linking context with reward: a functional circuit from hippocampal CA3 to ventral tegmental area. Science 2011, 333:353-357.
40. Legault M., Rompre P.P., Wise R.A. Chemical stimulation of the ventral hippocampus elevates nucleus accumbens dopamine by activating dopaminergic neurons of the ventral tegmental area. J Neurosci Off J Soc Neurosci 2000, 20:1635-1642.
41. Lisman J.E., Grace A.A. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 2005, 46:703-713.
42. Lisman J, Grace AA, Duzel E: A neoHebbian framework for episodic memory; role of dopamine-dependent late LTP. Trends Neurosci 2011, in press.
43. Lodge D.J., Grace A.A. Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia. Trends Pharmacol Sci 2011, 32:507-513.
44. Lodge D.J., Behrens M.M., Grace A.A. A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci Off J Soc Neurosci 2009, 29:2344-2354.
45. Lodge D.J., Grace A.A. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J Neurosci Off J Soc Neurosci 2007, 27:11424-11430.
46. Gruber A.J., Calhoon G.G., Shusterman I., Schoenbaum G., Roesch M.R., O'Donnell P. More is less: a disinhibited prefrontal cortex impairs cognitive flexibility. J Neurosci Off J Soc Neurosci 2010, 30:17102-17110.
47. Siekmeier P.J., Stufflebeam S.M. Patterns of spontaneous magnetoencephalographic activity in patients with schizophrenia. J Clin Neurophysiol Off Publ Am Electroencephalogr Soc 2010, 27:179-190.
48. Llinas R., Urbano F.J., Leznik E., Ramirez R.R., van Marle H.J. Rhythmic and dysrhythmic thalamocortical dynamics: GABA systems and the edge effect. Trends Neurosci 2005, 28:325-333.
49. Schulman J.J., Cancro R., Lowe S., Lu F., Walton K.D., Llinas R.R. Imaging of thalamocortical dysrhythmia in neuropsychiatry. Front Hum Neurosci 2011, 5:69.
50. Deakin J.F., Lees J., McKie S., Hallak J.E., Williams S.R., Dursun S.M. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. Arch Gen Psychiatry 2008, 65:154-164.
51. Steriade M. Grouping of brain rhythms in corticothalamic systems. Neuroscience 2006, 137:1087-1106.
52. Zhang Y., Llinas R.R., Lisman J.E. Inhibition of NMDARs in the nucleus reticularis of the thalamus produces delta frequency bursting. Front Neural Circuits 2009, 3:20.
53. Steriade M., Llinas R.R. The functional states of the thalamus and the associated neuronal interplay. Physiol Rev 1988, 68:649-742.
54. Kargieman L., Santana N., Mengod G., Celada P., Artigas F. NMDA antagonist and antipsychotic actions in cortico-subcortical circuits. Neurotox Res 2008, 14:129-140.
55. Kiss T., Hoffmann W.E., Scott L., Kawabe T.T., Milici A.J., Nilsen E.A., Hajos M. Role of thalamic projection in NMDA receptor-induced disruption of cortical slow oscillation and short-term plasticity. Front Psychiatry/Front Res Found 2011, 2:14.
56. Meador-Woodruff J.H., Clinton S.M., Beneyto M., McCullumsmith R.E. Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia. Ann N Y Acad Sci 2003, 1003:75-93.
57. Sharp F.R., Tomitaka M., Bernaudin M., Tomitaka S. Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?. Trends Neurosci 2001, 24:330-334.
58. Ferrarelli F., Tononi G. The thalamic reticular nucleus and schizophrenia. Schizophr Bull 2011, 37:306-315.
59. Vaisanen J., Ihalainen J., Tanila H., Castren E. Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia. Cell Mol Neurobiol 2004, 24:769-780.
60. Hoover W.B, Vertes R.P. Collateral projections from nucleus reuniens of thalamus to hippocampus and medial prefrontal cortex in the rat: a single and double retrograde fluorescent labeling study. Brain Struct Funct 2011.
61. Zhang Y., Lisman J. Ketamine Enhances Delta and Gamma Oscillations in Hippocampal Field Potentials 2010, Society for Neuroscience, San Diego, CA, Program#/Poster#: 880.13/NN4.
62. Schobel S.A., Lewandowski N.M., Corcoran C.M., Moore H., Brown T., Malaspina D., Small S.A. Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch Gen Psychiatry 2009, 66:938-946.
63. Lisman J.E., Pi H.J., Zhang Y., Otmakhova N.A. A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia. Biol Psychiatry 2010, 68:17-24.
64. Karavanova I., Vasudevan K., Cheng J., Buonanno A. Novel regional and developmental NMDA receptor expression patterns uncovered in NR2C subunit-beta-galactosidase knock-in mice. Mol Cell Neurosci 2007, 34:468-480.
65. Frith C.D The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychol Med 1987, 17:631-648.
66. Feinberg I. Efference copy and corollary discharge: implications for thinking and its disorders. Schizophr Bull 1978, 4:636-640.
67. Ford J.M., Mathalon D.H., Whitfield S., Faustman W.O., Roth W.T. Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biol Psychiatry 2002, 51:485-492.
68. Wurtz R.H., McAlonan K., Cavanaugh J., Berman R.A. Thalamic pathways for active vision. Trends Cogn Sci 2011, 15:177-184.
69. Kellendonk C., Simpson E.H., Kandel E.R. Modeling cognitive endophenotypes of schizophrenia in mice. Trends Neurosci 2009, 32:347-358.
70. Marenco S., Geramita M., van der Veen J.W., Barnett A.S., Kolachana B., Shen J., Weinberger D.R., Law A.J. Genetic association of ErbB4 and human cortical GABA levels in vivo. J Neurosci Off J Soc Neurosci 2011, 31:11628-11632.
71. Neddens J., Fish K.N., Tricoire L., Vullhorst D., Shamir A., Chung W., Lewis D.A., McBain C.J., Buonanno A. Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia. Biol Psychiatry 2011, 70:636-645.
72. Nason M.W., Adhikari A., Bozinoski M., Gordon J.A., Role L.W. Disrupted activity in the hippocampal-accumbens circuit of type III neuregulin 1 mutant mice. Neuropsychopharmacology Off Publ Am Coll Neuropsychopharmacol 2011, 36:488-496.
73. Cohen B.M., Cherkerzian S., Ma J., Ye N., Wager C., Lange N. Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs. Psychopharmacology 2003, 167:403-410.
74. Cohen B.M., Wan W., Froimowitz M.P., Ennulat D.J., Cherkerzian S., Konieczna H. Activation of midline thalamic nuclei by antipsychotic drugs. Psychopharmacology 1998, 135:37-43.